🟢 Neurosense Therapeutics is trading 10.77% up today amid volatility after reverse stock split

Neurosense Therapeutics is trading 10.77% up now at $6.89, with gains appearing primarily technical and highly volatile after its 1-for-20 reverse stock split.

• The 1-for-20 reverse stock split became effective September 14, 2026; Nasdaq confirmed it and the associated CUSIP change.
• The company’s H.C. Wainwright conference presentation is scheduled for 4:30 p.m. Eastern time September 15, 2026; no announced event clearly explains the gain.
• The broader market and biotech sector are lower, providing no strong same-direction explanation.